RECENT DEALS | PHARMACEUTICALS AND HEALTHCARE
Advising major international pharmaceuticals company Glenmark on several compliance issues, advertising law and activities aimed at promoting medical products on the Internet
Representing Japanese pharmaceutical company Santen in a dispute on debt recovery with a Russian distributor of medicines
Representing Abbott Laboratories in a dispute with pharmaceutical products distributors in Georgia
Advising Japanese pharmaceutical company Santen on day-to-day corporate matters in Russia
Advising Indian pharmaceutical company Ishvan Pharmaceuticals in the process of establishing a joint venture in Russia together with the National Immunobiological Company in order to set up full cycle manufacturing of medical products, as well as advising on the issues related to state procurement and obtaining single-supplier status
Providing legal support to the leading Russian manufacturer Biotiki of original metabolic drugs in connection with obtaining the extended manufacturing license (with inclusion of the new manufacturing site)
Advising PharmaKos, a company counseling pharmaceutical businesses around the world, on the issues regarding obtaining license for an American company purchasing crude drugs and starting materials in Russia and furnishing them to a Belorussian plant for further production of medicine, its bottling and packaging
Consulting, Pharmaceuticals and Healthcare: Corporate and M&A
Representing a major Irish pharmaceuticals company Mallinckrodt Pharmaceuticals in conducting a trademark transfer and protecting its rights in various Russian regions against numerous grey importers and online stores
Pharmaceuticals and Healthcare: Intellectual Property, Dispute Resolution
Representing global pharmaceutical company Merck Sharp & Dohme Corp in a patent infringement dispute in Belarus against a generic company winning a major public tender
Pharmaceuticals and Healthcare: Intellectual Property, Dispute Resolution
Advising an Indian pharmaceutical company Lupin, ranking among the top five pharmaceutical companies in the country and the top ten generics’ manufacturers in the world, on corporate restructuring and organization of operational activity in Russia